Juha Laine’s lecture Societal and economic impacts and value of advanced treatments for inflammatory diseases is held on 3 May at 3PM. After Laine’s lecture, Professor Mika Kortelainen will give a lecture Covid-19 Pandemic in Finland: Real-time health economic evaluation. Follow the webinar from here.

Docent Juha Laine has been appointed as Professor of Practice in Pharmacoeconomics. The appointment strengthen the operations of the InFLAMES Flagship, joint effort of the University of Turku and Åbo Akademi University, funded by the Academy of Finland. The purpose behind the professorship of practice in pharmacoeconomics is to increase the societal impact of research and collaboration between the University and pharmaceutical companies.

The newly-appointed Professor of Practice in Pharmacoeconomics Juha Laine has a PhD in Health Economics and is Docent of Pharmacoeconomics and Health Economics. Laine works in the pharmaceutical company Roche. In his job, he is responsible for coordinating research that uses real world data such as register-based research while also working as a health economics advisor. The University of Turku has had a collaboration agreement with Roche since 2018. Laine’s recruitment as a professor of practise is an additional step in the co-operation of Roche and the University of Turku.